Literature DB >> 3392660

Carrier-mediated transport of cefixime, a new cephalosporin antibiotic, via an organic anion transport system in the rat renal brush-border membrane.

I Tamai1, A Tsuji, Y Kin.   

Abstract

The renal excretion mechanism of cefixime, a newly developed and p.o. effective cephalosporin antibiotic, was investigated by using the renal brush-border membrane vesicles from the rat kidney cortex. The initial uptake rate of cefixime into an osmotically sensitive vesicular space showed concentration and temperature dependencies, indicating the presence of a carrier-mediated transport mechanism for cefixime. Kinetic parameters for apparently saturable and nonsaturable components were evaluated as follows: maximum uptake rate was 7.32 +/- 1.07 nmol/30 sec/mg of protein; Michaelis constant was 7.35 +/- 2.04 mM; and the first-order rate constant was 0.34 +/- 0.02 nmol/30 sec/mg of protein per mM. The uptake was not affected by an inward-directed gradient of Na+, K+, Li+, Rb+ or H+. In contrast, the initial uptake rate was enhanced by an inside-positive membrane potential imposed by valinomycin. Although amino acids, dipeptides and organic cations had no effects on the uptake of cefixime, organic anions such as probenecid and p-aminohippuric acid and anion transport inhibitors such as 4,4'-diisothiocyano-stilbene-2,2'-disulfonic acid and furosemide reduced the uptake significantly. Twenty beta-lactam antibiotics including both zwitter-ionic and anionic derivatives inhibited significantly the uptake of cefixime. Furthermore, by adding probenecid in the extravesicular medium, an efflux of cefixime from the brush-border membrane vesicles was enhanced significantly at the initial stage. Benzylpenicillin, cephalothin and cephradine also enhanced an efflux of cefixime to the same extent as observed by the addition of probenecid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392660

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Transport mechanism of ceftibuten, a dianionic cephem, in rat renal brush-border membrane.

Authors:  I Naasani; M Sugawara; M Kobayashi; K Iseki; K Miyazaki
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Restricted intestinal absorption of some beta-lactam antibiotics by an energy-dependent efflux system in rat intestine.

Authors:  H Saitoh; H Fujisaki; B J Aungst; K Miyazaki
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

4.  Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1.

Authors:  H Uchino; I Tamai; H Yabuuchi; K China; K Miyamoto; E Takeda; A Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 5.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

6.  Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics.

Authors:  Masanori Nakakariya; Taiki Shimada; Masanori Irokawa; Hiroyuki Koibuchi; Takashi Iwanaga; Hikaru Yabuuchi; Tomoji Maeda; Ikumi Tamai
Journal:  Pharm Res       Date:  2007-09-22       Impact factor: 4.200

7.  Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.

Authors:  C A Rodriguez; D E Smith
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney.

Authors:  Christopher S Lepsy; Robert J Guttendorf; Alan R Kugler; David E Smith
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.